{"name":"Melius Pharma AB","slug":"melius-pharma-ab","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMisgJBVV95cUxOb2FpNnlvQ2NMX0ZSTnZkdGtFUXhFUzhyRXA4SjJQcF9uOHZRaWJDZ1hDUnZ0T0pLWmthYWRmM2NGTVNDZkFOQnZPbFlhY0lNUnJmNkpnYll3eERNOW8wVS1VMFV2QnE5bWMzZDBFcGduUUpqaDBpZGtSNlE1SDVDRTMxNENyMFJud3F0S3pyUi1rMHZhZ1JhUHNtc1VScWZoZkszc0lMYVFOaWhpUk5QMVhtbl92VU9WWlJnR2VwSnp5elhiV1hENHVXV0FpemhUa29jd0JxUGJqWnVFcTZ2dnAxWDQ4LTN4T3pyZ0xIcWtJdFk3dFVqaEp2cng2b0lSOTd0YTVQNGFXMzZteTA0N3VpbDg0U3dDT2J2QVliNGdPUldNa0Zndi1mRzZ3a3h1dHc?oc=5","date":"2026-02-09","type":"trial","source":"GlobeNewswire","summary":"Idiopathic Pulmonary Fibrosis Clinical Trials & Pipeline - GlobeNewswire","headline":"Idiopathic Pulmonary Fibrosis Clinical Trials & Pipeline","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwJBVV95cUxPaXRELXRlVG9TNUMwN1ZMX3NsM2dzaGp1b0I5ZmtUaF9oWUQxWkZGMGN0cm1ZZ1AtR2U0LVNlOVB0X2xHTE9Ub29yWXU4Vm9TTmtLTHNocXpJOFk3QnJQRDNrcmxGcE11TURRZE54RS02RjZRX3FNOXA3cDVHWjBDY09GdHhJMzh2MEtVMTdzSlZQQWZfUDhSUS14UHZZTWZWRHVvRHdMa2tsc1J0S1E5QTJTQ01IT0VwYTFjalVVcVAtaVVrVFZYVklSVVVucFVIU3BieGw5ajZ3WTFPekNoemlqVFdlUE9LcE1Pa0R4b0tYdzFvMzhmZWF2LVVPYmRvbWJLd3RQM1BHblZjYkRRRG8zMHJvZms?oc=5","date":"2025-11-24","type":"pipeline","source":"GlobeNewswire","summary":"Chronic Refractory Cough Market is Expected to Boom by 2034 - GlobeNewswire","headline":"Chronic Refractory Cough Market is Expected to Boom by 2034","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgJBVV95cUxPODR6a0JUUjQ2d3pHa2c0M3gtN2ZRMDVGandaRFJha3VIMjg3OEdjWTRZTk1uMlV4Z3ktQUhXZGgxNW9oYmRPQ29NSlpwYklHenlyOElhTnhHTENKZldhZ1JiZ3RWU19CLW5vRUVGWEpneEs4dGY5V1gxRnhHanA2Ni1qQno5SnkyZG40dWxyYWVzVFM4Z2hKaHJqTlg2OEkzTnhMd0hveW5vdEhiRENMVEFxTlVtV1ZwejdjVHhnVlYtR1lhbDVuRzU3YlVETDR3bjhhZm40LWVNcUpKQVdpY2FHZl9JTWQ2VDVRR19KdjFVd1o5RUQzOERDMkZQcEpLWTNwZVJtcjgzR2ppYUJRS01kMnUxOUpLSDlwWFVHT19EaVZDSFhaS2F5cHpNa0MwZjcwVXY1X0dSejgwNUE?oc=5","date":"2025-01-28","type":"trial","source":"GlobeNewswire","summary":"Pulmonary Fibrosis Clinical Trial Pipeline Appears Robust - GlobeNewswire","headline":"Pulmonary Fibrosis Clinical Trial Pipeline Appears Robust","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwJBVV95cUxNVGhpZEFiUzhvRU5fTEFRVm51dXgyT1E2WDVDZ1UxYTJQdi1UV0w4eVhwSGN4Z2wyUk1nUmdSbGZXcGpzb2RzNTNwNWpTTHZiSUJ2ZFlyMUFxMzFXcDNEZTNnd1k0ZkRTVW11UW01SEJval8wc3RaQmJ4UGJYeFAtOXBQcmxSMWYxX3BEejViZEQ0NU5sdldoNWlCVnRpWEVUZVZ5Mm5ScXdtbGVXR2JmSVhia091d1QyRDZ4UXE2cHlNMXpJaUtKX3FYZDB5ZkZfT3k2dFREMzBRdnlWTnNmOFItYy16VjFVMUNhYUFvMlZpbnBzeUdPWHN2R1YxbEwzU1JlaDhKSldqTWs?oc=5","date":"2024-04-03","type":"pipeline","source":"PR Newswire","summary":"Cough in Idiopathic Pulmonary Fibrosis Therapeutics Market to Exhibit Immense Growth at a CAGR of 4.9% by 2034 | DelveInsight - PR Newswire","headline":"Cough in Idiopathic Pulmonary Fibrosis Therapeutics Market to Exhibit Immense Growth at a CAGR of 4.9% by 2034 | DelveIn","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}